Back to NISA Investment Advisors, LLC NISA Investment Advisors, LLC

AXSM

29 quarters

Position history for NISA Investment Advisors, LLCNISA Investment Advisors, LLC's holdings in Axsome Therapeutics, Inc.

Yes. NISA Investment Advisors holds 388 shares of AXSM (Axsome Therapeutics), worth $71,543, as of its Q3 2026 13F filing. It reduced the position by 492 shares (-55.9%) from Q2 2026. NISA Investment Advisors has held AXSM since Q3 2019, across 29 quarterly 13F filings.

Current Value

$71,543

Current Shares

388

Total Value Change

+$65,543

Total Shares Change

+88

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
388
-55.9%
$71,5430.0%$184.39
0
2026-Q2
Decreased
880
-15.3%
$215,3980.0%$244.77
0
2026-Q1
Increased
1,039
+0.3%
$175,6120.0%$169.02
23
2025-Q4
Decreased
1,036
-4.3%
$189,2150.0%$182.64
0
2025-Q3
Increased
1,082
+5.4%
$131,4090.0%$121.45
23
2025-Q2
Decreased
1,027
-1.9%
$107,2090.0%$104.39
0
2025-Q1
Decreased
1,047
-2.4%
$122,1120.0%$116.63
0
2024-Q4
Increased
1,073
+4.9%
$90,7870.0%$84.61
23
2024-Q3
Increased
1,023
+3.8%
$91,9370.0%$89.87
22
2024-Q2
Increased
986
+4.1%
$79,3730.0%$80.50
22
2024-Q1
Increased
947
+2.8%
$75,5710.0%$79.80
22
2023-Q4
Increased
921
+0.6%
$73,3020.0%$79.59
21
2023-Q3
Unchanged
916
0.0%
$64,0190.0%$69.89
0
2023-Q2
Increased
916
+10.9%
$65,8240.0%$71.86
23
2023-Q1
Unchanged
826
0.0%
$51,0000.0%$61.68
0
2022-Q4
Unchanged
826
0.0%
$64,0000.0%$77.13
0
2022-Q3
Decreased
826
-7.0%
$37,0000.0%$44.62
0
2022-Q2
Increased
888
+208.3%
$34,0000.0%$38.30
32
2022-Q1
Decreased
288
-86.1%
$12,0000.0%$41.39
0
2021-Q4
Increased
2,078
+324.1%
$57,0000.0%$37.78
33
2021-Q3
Decreased
490
-81.7%
$16,0000.0%$32.96
0
2021-Q2
Decreased
2,671
-8.6%
$180,0000.0%$67.46
0
2021-Q1
Unchanged
2,921
0.0%
$165,0000.0%$56.62
0
2020-Q4
Increased
2,921
+70.3%
$238,0000.0%$81.47
34
2020-Q3
Decreased
1,715
-31.7%
$122,0000.0%$71.25
0
2020-Q2
Increased
2,512
+1041.8%
$207,0000.0%$82.28
37
2020-Q1
Decreased
220
-26.7%
$13,0000.0%$58.83
0
2019-Q4
Unchanged
300
0.0%
$31,0000.0%$103.36
0
2019-Q3
New
300
-
$6,0000.0%$20.24
22

Other major holders of AXSM: Vanguard Group Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used